Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.

LATEST BREAST CANCER CONTENT

Changing ADC Choices for HR+/HER2– Breast Cancer

Assessing Genomic Assays in Early-Stage Invasive Breast Cancer

Navigating Genomic Assays and Clinical Evidence in Early Breast Cancer

Optimizing Breast Cancer Care With Predictive and Prognostic Assays

Balancing Efficacy and Toxicity of Oral SERDs in Breast Cancer

Trials Demonstrate First-Line Role of Sacituzumab in Metastatic TNBC

Oncologists Discuss Optimizing the Use of Elacestrant in Breast Cancer

Selecting Second-Line Treatment in HR+, HER2-Low Breast Cancer

CASE-BASED ROUNDTABLES

Multigene Expression Testing in Early-Stage Breast Cancer Management

HER2+ Breast Cancer Treated With Antibody-Drug Conjugates

Therapeutic Choices for Patients With HR-Positive, HER2-Low Breast Cancer

Treating Patients With Breast Cancer After Progression on Endocrine Therapy

CDK Inhibition in HR-Positive, HER2-Negative Early-Stage Breast Cancer

January 24, 2022

Later-Line Choices for Patients With Metastatic Breast Cancer

December 29, 2021

Deciding Management for Early HER2-Positive Breast Cancer

December 24, 2021